The weight-loss drugs market is set to grow to around Rs 5,000 crore in India by 2030, up from Rs 1,000 crore at present, ...
GLP-1 receptor agonists have gained attention as medications to manage type 2 diabetes and obesity. Drugs such as semaglutide and tirzepatide help regulate blood sugar and reduce appetite, which can ...